Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Reincke

Showing results (261-270 of 468) with videos related to

Pageof 47
Sort By:
Hypertension (Dallas, Tex. : 1979)|December 25, 2018
Proteomic Landscape of Aldosterone-Producing AdenomaMarta M Swierczynska, Matthias J Betz, Marco Colombi, et al.
Frontiers in Endocrinology|March 25, 2025
Wnt/β-catenin pathway activation is associated with glucocorticoid secretion in adrenocortical carcinoma, but not directly with immune cell infiltrationTanja Maier, Laura-Sophie Landwehr, Alexandra Triebig, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 9, 2017
Reference intervals for plasma concentrations of adrenal steroids measured by LC-MS/MS: Impact of gender, age, oral contraceptives, body mass index and blood pressure statusGraeme Eisenhofer, Mirko Peitzsch, Denise Kaden, et al.
European Journal of Endocrinology|August 28, 2015
Increased prevalence of diabetes mellitus and the metabolic syndrome in patients with primary aldosteronism of the German Conn's RegistryGregor Hanslik, Henri Wallaschofski, Anna Dietz, et al.
The Journal of Clinical Endocrinology and Metabolism|April 13, 2019
Plasma Steroid Profiles in Subclinical Compared With Overt Adrenal Cushing SyndromeJimmy Masjkur, Matthias Gruber, Mirko Peitzsch, et al.
Hypertension (Dallas, Tex. : 1979)|December 12, 2023
Long-Term Follow-Up of Patients With Elevated Aldosterone-to-Renin Ratio but Negative Confirmatory Test: The Progression of Primary Aldosteronism PhenotypesFabrizio Buffolo, Alessio Pecori, Martin Reincke, et al.
Environmental Research|March 21, 2025
The impact of endocrine disrupting chemicals on adrenal corticosteroids - A systematic review of epidemiological studiesIsabel Stüfchen, Júnia R O L Schweizer, Friederike Völter, et al.
Journal of Hypertension|September 5, 2020
Subtype diagnosis, treatment, complications and outcomes of primary aldosteronism and future direction of research: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of HypertensionPaolo Mulatero, Leonardo A Sechi, Tracy Ann Williams, et al.
The Journal of Endocrinology|December 17, 2025
Immunohistochemistry-guided analyses of steroidogenesis in primary bilateral macronodular adrenal hyperplasiaSharmilee Vetrivel, Sara Jung, XiaoHui Xia, et al.
Hypertension (Dallas, Tex. : 1979)|May 8, 2026
Pregnancy-Related Complications in Primary Aldosteronism: A European SurveyVittorio Forestiero, Juan Solorzano Roa, Ester Landau, et al.
Pageof 47

Showing results (261-270 of 468) with videos related to

Sort By:
Pageof 47
Hypertension (Dallas, Tex. : 1979)|December 25, 2018
Proteomic Landscape of Aldosterone-Producing AdenomaMarta M Swierczynska, Matthias J Betz, Marco Colombi, et al.
Frontiers in Endocrinology|March 25, 2025
Wnt/β-catenin pathway activation is associated with glucocorticoid secretion in adrenocortical carcinoma, but not directly with immune cell infiltrationTanja Maier, Laura-Sophie Landwehr, Alexandra Triebig, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 9, 2017
Reference intervals for plasma concentrations of adrenal steroids measured by LC-MS/MS: Impact of gender, age, oral contraceptives, body mass index and blood pressure statusGraeme Eisenhofer, Mirko Peitzsch, Denise Kaden, et al.
European Journal of Endocrinology|August 28, 2015
Increased prevalence of diabetes mellitus and the metabolic syndrome in patients with primary aldosteronism of the German Conn's RegistryGregor Hanslik, Henri Wallaschofski, Anna Dietz, et al.
The Journal of Clinical Endocrinology and Metabolism|April 13, 2019
Plasma Steroid Profiles in Subclinical Compared With Overt Adrenal Cushing SyndromeJimmy Masjkur, Matthias Gruber, Mirko Peitzsch, et al.
Hypertension (Dallas, Tex. : 1979)|December 12, 2023
Long-Term Follow-Up of Patients With Elevated Aldosterone-to-Renin Ratio but Negative Confirmatory Test: The Progression of Primary Aldosteronism PhenotypesFabrizio Buffolo, Alessio Pecori, Martin Reincke, et al.
Environmental Research|March 21, 2025
The impact of endocrine disrupting chemicals on adrenal corticosteroids - A systematic review of epidemiological studiesIsabel Stüfchen, Júnia R O L Schweizer, Friederike Völter, et al.
Journal of Hypertension|September 5, 2020
Subtype diagnosis, treatment, complications and outcomes of primary aldosteronism and future direction of research: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of HypertensionPaolo Mulatero, Leonardo A Sechi, Tracy Ann Williams, et al.
The Journal of Endocrinology|December 17, 2025
Immunohistochemistry-guided analyses of steroidogenesis in primary bilateral macronodular adrenal hyperplasiaSharmilee Vetrivel, Sara Jung, XiaoHui Xia, et al.
Hypertension (Dallas, Tex. : 1979)|May 8, 2026
Pregnancy-Related Complications in Primary Aldosteronism: A European SurveyVittorio Forestiero, Juan Solorzano Roa, Ester Landau, et al.
Pageof 47